Market Overview:
The global haemodialysers market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of renal failure, rising geriatric population, and technological advancements in haemodialysis products. The global haemodialysers market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into low flux membrane and high flux membrane. On the basis of application, the market is segmented into hospitals, clinic centers, and others (home-based dialysis). The hospitals segment accounted for a major share of the global haemodialysers market in 2017 owing to increased prevalence of renal failure and growing number of patients undergoing dialysis in hospitals.
Product Definition:
Haemodialysers are devices used to remove waste products and excess fluid from the blood. This is important because it helps to protect the kidneys from damage and can improve the patient's overall health.
Low Flux Membrane:
A low flux membrane is a type of dialysis membrane that has lower surface area to volume ratio than regular membranes. The reduced surface area to volume ratio results in higher permeability for water and other solutes. This allows the blood purification process by removing impurities present in the blood with greater ease and efficiency compared to standard membranes resulting in increased demand for low-flux membranes over conventional ones.
High Flux Membrane:
High Flux Membrane (HFM) is a type of membrane filter used in hemodialysis. It helps to remove blood proteins, RBCs and WBCs from the blood circulation. The process of hemodialysis is performed by machines that separate the kidney from the liver and it's functions in removing waste products from blood using this membrane filtration process.
Application Insights:
The market is segmented into hospitals, clinic centers, and others. The hospitals segment dominated the application arena in 2017 owing to increasing prevalence of cardiovascular diseases and rising number of dialysis patients. According to a study published by the CDC in November 2016, around 517 thousand people were living with kidney failure in the U.S., out of which approximately 202 thousand were on chronic dialysis or had a kidney transplant while 294 thousand were receiving regular dialysis treatment. Thus, increasing incidence of chronic diseases related to kidneys coupled with rising number of patients requiring haemodialysers is expected to drive demand for these machines over the forecast period.
The Clinic Centers segment is expected register significant growth over the forecast period due largely to growing awareness about availability and affordability associated with homecare settings as compared to hospital-based care settings for various medical conditions including diabetes mellitus type 2 and CKD (chronic kidney disease).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region. The U.S.-based company Columbia River Haemodialysis has a virtual monopoly in the North American market owing to its early adoption of this technology and because it is one of the few companies that manufactures both low- and high-flux membranes.
Asia Pacific is expected to be fastest growing regional market over the forecast period due to rising patient affordability, improving economic conditions leading to increased disease prevalence rates, and increasing government initiatives for spreading awareness regarding hemodialysis procedures & products.
Growth Factors:
- Increasing incidence of renal diseases: The global prevalence of chronic kidney disease (CKD) is estimated to be around 10%. This number is expected to grow in the coming years due to the increasing incidence of diabetes and hypertension. This will create a larger pool of patients who will require haemodialysis treatment.
- Technological advancements: There has been a steady increase in the number of dialysis centres over the past few years, owing to technological advancements that have made haemodialysis more efficient and less time-consuming. These advancements are also helping to reduce costs, making haemodialysis more affordable for patients.
- Growing awareness about renal health: There is growing awareness among people about the importance of maintaining good renal health and taking steps to prevent or delay onset of CKD. This is driving demand for haemodialysis services worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Haemodialysers Market Research Report
By Type
Low Flux Membrane, High Flux Membrane
By Application
Hospitals, Clinic Centers, Others
By Companies
Fresenius, Baxter, NIPRO, B. Braun, Asahi Kasei, NIKKISO, Toray, Haidylena, Medica, Kawasumi Laboratories, WEIGAO, Allmed, Farmasol, Shanghai Peony Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Haemodialysers Market Report Segments:
The global Haemodialysers market is segmented on the basis of:
Types
Low Flux Membrane, High Flux Membrane
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius
- Baxter
- NIPRO
- B. Braun
- Asahi Kasei
- NIKKISO
- Toray
- Haidylena
- Medica
- Kawasumi Laboratories
- WEIGAO
- Allmed
- Farmasol
- Shanghai Peony Medical
Highlights of The Haemodialysers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Low Flux Membrane
- High Flux Membrane
- By Application:
- Hospitals
- Clinic Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Haemodialysers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Haemodialysis is a process of removing waste and toxins from the blood using an artificial kidney. Dialysis uses a machine to remove waste and toxins from the blood over a period of time.
Some of the major companies in the haemodialysers market are Fresenius, Baxter, NIPRO, B. Braun, Asahi Kasei, NIKKISO, Toray, Haidylena, Medica, Kawasumi Laboratories, WEIGAO, Allmed, Farmasol, Shanghai Peony Medical.
The haemodialysers market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Haemodialysers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Haemodialysers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Haemodialysers Market - Supply Chain
4.5. Global Haemodialysers Market Forecast
4.5.1. Haemodialysers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Haemodialysers Market Size (000 Units) and Y-o-Y Growth
4.5.3. Haemodialysers Market Absolute $ Opportunity
5. Global Haemodialysers Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Haemodialysers Market Size and Volume Forecast by Type
5.3.1. Low Flux Membrane
5.3.2. High Flux Membrane
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Haemodialysers Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Haemodialysers Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinic Centers
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Haemodialysers Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Haemodialysers Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Haemodialysers Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Haemodialysers Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Haemodialysers Demand Share Forecast, 2019-2026
9. North America Haemodialysers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Haemodialysers Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Haemodialysers Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinic Centers
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Haemodialysers Market Size and Volume Forecast by Type
9.7.1. Low Flux Membrane
9.7.2. High Flux Membrane
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Haemodialysers Demand Share Forecast, 2019-2026
10. Latin America Haemodialysers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Haemodialysers Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Haemodialysers Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinic Centers
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Haemodialysers Market Size and Volume Forecast by Type
10.7.1. Low Flux Membrane
10.7.2. High Flux Membrane
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Haemodialysers Demand Share Forecast, 2019-2026
11. Europe Haemodialysers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Haemodialysers Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Haemodialysers Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinic Centers
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Haemodialysers Market Size and Volume Forecast by Type
11.7.1. Low Flux Membrane
11.7.2. High Flux Membrane
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potntial Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Haemodialysers Demand Share, 2019-2026
12. Asia Pacific Haemodialysers Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Haemodialysers Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Haemodialysers Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinic Centers
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Haemodialysers Market Size and Volume Forecast by Type
12.7.1. Low Flux Membrane
12.7.2. High Flux Membrane
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Haemodialysers Demand Share, 2019-2026
13. Middle East & Africa Haemodialysers Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Haemodialysers Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Haemodialysers Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinic Centers
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Haemodialysers Market Size and Volume Forecast by Type
13.7.1. Low Flux Membrane
13.7.2. High Flux Membrane
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Haemodialysers Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Haemodialysers Market: Market Share Analysis
14.2. Haemodialysers Distributors and Customers
14.3. Haemodialysers Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Fresenius
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. NIPRO
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. B. Braun
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Asahi Kasei
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. NIKKISO
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Toray
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Haidylena
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Medica
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Kawasumi Laboratories
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. WEIGAO
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Allmed
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Farmasol
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Shanghai Peony Medical
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
